Releasing a medical product to the public can be very complex. Companies have to meet several federal regulations in order to prove their products are safe. Even then these companies must account for the side effects their product could cause. So, what happens when a company doesn't follow these procedures? Ask the executive board of Johnson & Johnson Pharmaceuticals, it's been having a pretty rough year.